Literature DB >> 17143047

Dietary vitamin K intake and anticoagulation in elderly patients.

Luis Eduardo Rohde1, Michelli Cristina Silva de Assis, Eneida Rejane Rabelo.   

Abstract

PURPOSE OF REVIEW: Vitamin K is an essential co-factor for the synthesis of several coagulation factors. Oral anticoagulants competitively inhibit enzymes that participate in vitamin K metabolism. The purpose of this review is to evaluate the potential interaction of dietary vitamin K and coagulation stability, particularly in the elderly patient. RECENT
FINDINGS: Recent prospective evidences suggest that dietary vitamin K plays an essential role in anticoagulation stability. Vitamin K intake of more than 250 microg/day was shown to decrease warfarin sensitivity in anticoagulated patients consuming regular diets. In a randomized crossover study, brief periods of changes on vitamin K intake also had significant effects on coagulation parameters. Patients that were allocated to an 80% decrease of intake increased International Normalized Ratio (INR) by almost 30% 7 days after the intervention. Similarly, it was estimated by dietary records that for each increase in 100 microg of vitamin K intake, the INR would be reduced by 0.2. A recent study also demonstrated that over-the-counter multivitamin supplements contain enough vitamin K1 to significantly alter coagulation parameters.
SUMMARY: Contemporary data strengthen the concept that the interaction between dietary vitamin K and coumarin derivatives is clinically relevant and plays a major role in INR fluctuations in chronic anticoagulated patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143047     DOI: 10.1097/MCO.0b013e328011c46c

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  8 in total

Review 1.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

Review 2.  [Oral anticoagulation using coumarins - an update].

Authors:  Christoph Sucker; Jens Litmathe
Journal:  Wien Med Wochenschr       Date:  2017-06-12

3.  Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario.

Authors:  Devendra Saksena; Yugal K Mishra; S Muralidharan; Vivek Kanhere; Pankaj Srivastava; C P Srivastava
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-01-28

4.  Novel anticoagulants in atrial fibrillation stroke prevention.

Authors:  Nicholas B Norgard; James J Dinicolantonio; Taylor J Topping; Benjamin Wee
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

5.  Influence of VKORC1 gene polymorphisms on the effect of oral vitamin K supplementation in over-anticoagulated patients.

Authors:  Priccila Zuchinali; Gabriela C Souza; Graziella Aliti; Mariana R Botton; Lívia Goldraich; Katia G Santos; Mara H Hutz; Eliane Bandinelli; Luis E Rohde
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

6.  Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats.

Authors:  Agnes Grandemange; Michael Hans Kohn; Romain Lasseur; Christiane Longin-Sauvageon; Philippe Berny; Etienne Benoit
Journal:  Pharmacogenet Genomics       Date:  2009-10       Impact factor: 2.089

7.  A Novel LC-MS/MS Assay for Quantification of Des-carboxy Prothrombin and Characterization of Warfarin-Induced Changes.

Authors:  Abdul Basit; Bhagwat Prasad; Joanne K Estergreen; Daniel E Sabath; Nathan Alade; David L Veenstra; Allan E Rettie; Kenneth E Thummel
Journal:  Clin Transl Sci       Date:  2020-03-09       Impact factor: 4.689

8.  Nutritional management of a patient with obesity and pulmonary embolism: a case report.

Authors:  Maria Luisa Fonte; Lauren Fietchner; Matteo Manuelli; Hellas Cena
Journal:  Nutr J       Date:  2016-10-19       Impact factor: 3.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.